Double-blind, Randomised, Multicentre Endocrine Trial Comparing Two Letrozole Doses, in Postmenopausal Breast Cancer Patients

Author： Bajetta E.   Zilembo N.   Dowsett M.   Guillevin L.   Di Leo A.   Celio L.   Martinetti A.   Marchiano A.   Pozzi P.   Stani S.   Bichisao E.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.35, Iss.2, 1999-02, pp. : 208-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Randomised Trial Comparing Two Doses of the New Selective Aromatase Inhibitor Anastrozole (Arimidex) With Megestrol Acetate in Postmenopausal Patients With Advanced Breast Cancer

By Berry J.   Sahlberg P.   ARIMIDEX Study Group   Jonat W.   Howell A.   Blomqvist C.   Eiermann W.   Winblad G.   Tyrrell C.   Mauriac L.   Roche H.   Lundgren S.   Hellmund R.   Azab M.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 404-412

Elsevier

Access to resources Recommend Favorite

A Randomised Double-blind Placebo Controlled Clinical Trial Assessing the Tolerability and Efficacy of Glutathione as an Adjuvant to Escalating Doses of Cisplatin in the Treatment of Advanced Ovarian Cancer

By Parnis F.X.   Coleman R.E.   Harper P.G.   Pickering D.   Topham C.   Whittington J.R.   Tedeschi M.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1721-1721

Elsevier

Access to resources Recommend Favorite

A Double-blind, Randomised Comparison of the Anti-emetic Efficacy of Two Intravenous Doses of Dolasetron Mesilate and Granisetron in Patients Receiving High Dose Cisplatin Chemotherapy

By on behalf of the European Dolasetron Comparative Study Group   Audhuy B.   Cappelaere P.   Martin M.   Cervantes A.   Fabbro M.   Riviere A.   Khayat D.   Bleiberg H.   Faraldi M.   Claverie N.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 807-813

Elsevier

Access to resources Recommend Favorite

A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients

By Hardy J.   Daly S.   McQuade B.   Albertsson M.   Chimontsi-Kypriou V.   Stathopoulos G.   Curtis P.  

Supportive Care in Cancer, Vol. 10, Iss. 3, 2002-04 ,pp. : 231-236

Springer Publishing Company

Access to resources Recommend Favorite

Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial

By Ozturk B.   Egehan I.   Atavci S.   Kitapci M.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 213-219

Elsevier

Access to resources Recommend Favorite